High Tide Inc. engages in the cannabis retail business in Canada, Europe, the United States, and internationally.
$2.63-6.41%
报价 2026-11-06
市值
$234.4M
EV
–
PE (TTM)
–
预期 PE
–
52 周区间距高点 -12.3%
$2.05$3.00
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Medical - Pharmaceuticals| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| HITIHigh Tide Inc. | $234.4M | -6.4% | – | 26.5% | – | – | – | |
| LTGOLatigo Biotherapeutics Inc. | $757.9M | -3.2% | – | – | – | – | – | |
| CGEMCullinan Therapeutics, Inc. | $695.1M | +4.7% | +142.3% | 0% | – | – | – | |
| VCREVicore Pharma Holding AB | $293.8M | +3.9% | – | 81% | – | – | – | |
| CUVLClinuvel Pharmaceuticals Ltd. | $257.5M | +1.6% | – | – | – | – | – | |
| ETRAElectra Therapeutics Inc. | $165.5M | +6.1% | – | – | – | – | – | |
| LFMDLifeMD, Inc. | $114.4M | +3.5% | -5.1% | 85.9% | – | – | – | |
| TRXBTRex Bio Inc. | $110.5M | +2.1% | – | – | – | – | – | |
| RNTXRein Therapeutics Inc. | $52.9M | +0.3% | – | 0% | – | – | – | |
| 同行中位数 | – | – | +68.6% | 40.5% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
报告货币 CAD（非美元）| Metric | 2026-07-31 Q3 2026 | 2026-04-30 Q2 2026 | 2026-01-31 Q1 2026 | 2025-10-31 Q4 2025 | 2025-07-31 Q3 2025 | 2025-04-30 Q2 2025 | 2025-01-31 Q1 2025 | 2024-10-31 Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | CAD 198.8M | CAD 179.3M | CAD 178.6M | CAD 164M | CAD 149.7M | CAD 137.8M | CAD 142.5M | CAD 138.3M |
| Gross Margin | 26.5% | 27% | 8.4% | 25.9% | 26.8% | 25.7% | 24.9% | 25.9% |
| Operating Margin | 4.4% | 4.5% | 2.3% | -11.7% | 2.5% | 0.7% | 0% | -2% |
| Net Income | CAD 11.3M | CAD -197,000 | CAD 1.2M | CAD -45.6M | CAD 598,000 | CAD -2.9M | CAD -2.8M | CAD -4.7M |
| Diluted EPS | 0.12 | -0 | 0.01 | -0.52 | 0.01 | -0.04 | -0.04 | -0 |
| Operating Cash Flow | CAD 10.2M | CAD 4.4M | CAD 5.9M | CAD 4.3M | CAD 10.7M | CAD 8.3M | CAD 682,000 | CAD 9.7M |
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。